Preview Mode Links will not work in preview mode


Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of precision medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age-related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Dec 16, 2022

Virginia Halsey, Vice President of Product Management at FDB,  First Databank, is focused on helping pharmacists use drug interaction information, drug alerts and dosage data in smarter, more efficient ways.  WIth patient safety in mind, FDB is arming pharmacists with relevant content to determine the clinical impact of a specific drug on a specific patient.

Virginia elaborates, "First Databank is drug content, but a very specific niche of drug content in that it is structured in such a way that it's built into the workflow of other systems. So, for instance, if a patient goes into a retail pharmacy, the pharmacist behind the counter is using their system to basically fill the prescription, adjudicate the claim, and so forth. But that drug content that's within their system comes from First Databank. Content that describes the products that are available, the pricing, and most importantly, clinical information about the drug, such as what's the appropriate dose or what are the drug interactions."

"It's saving time, and it's addressing cognitive overload. So yes, the pharmacist can read this list of potential safety issues and interpret it, but there are a couple of problems. One is that then you have to take that time to sort through and think about the alternatives, maybe look something up. The other is, then, you get a lack of standardization because one pharmacist may come to one conclusion. Another may come to another conclusion instead of having standardized practice protocols and alternatives."

@FDB_US #FirstDatabank #Pharmacy #Healthtech #Pharmacists #MedicationGuidance #HIT

Listen to the podcast here